Remicade and Repatha drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remicade (infliximab) and Repatha (evolocumab). Common drug interactions include injection site pain among females and anaphylactic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Remicade and Repatha. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,256 Repatha users. Check the latest studies of Repatha.

On Jul, 15, 2026

11 people who take Remicade and Repatha together, and have interactions are studied.

What are the common drug interactions of Remicade and Repatha, by gender? *:

female:

Injection site pain
Adverse drug reaction
Back pain
Balance disorder
Cerebral disorder (brain disease)
Dizziness
Influenza like illness
Oral discomfort (pain or irritation in mouth)
Palpitations (feelings or sensations that your heart is pounding or racing)
Rash

male:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Infusion related reaction
Arthralgia (joint pain)
Constipation
Gait disturbance
Injection site mass
Injection site pain
Insomnia (sleeplessness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Remicade and Repatha, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Infusion related reaction
Adverse drug reaction
Dizziness
Influenza like illness
Oral discomfort (pain or irritation in mouth)
Throat tightness
White blood cell count decreased

60+:

Injection site pain
Arthralgia (joint pain)
Constipation
Gait disturbance
Injection site mass
Insomnia (sleeplessness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Neuropathy peripheral (surface nerve damage)
Palpitations (feelings or sensations that your heart is pounding or racing)
Rash

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 18.18%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
Prostatic Disorder: 1 person, 9.09%
Pain: 1 person, 9.09%
Osteoporotic Fracture (fracture due to weak bone): 1 person, 9.09%
Inflammation: 1 person, 9.09%
Indigestion: 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and Repatha?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously